CVS Caremark recently announced that its overall prescription drug trend for 2020 was 2.9 percent, while there was a negative trend for 34 percent of commercial pharmacy benefit management (PBM)...
CVS Health recently announced that it began administering COVID-19 vaccines at workplace vaccination sites to increase access to vaccinations.
The vaccination increase comes on the heels of...
Gavi, the Vaccine Alliance, recently announced that it signed an advance purchase agreement with Moderna for 500 million doses of its mRNA COVID-19 vaccine.
The initial supply under the...
Moderna recently announced that it will increase global 2022 capacity for its COVID-19 vaccine to up to 3 billion doses, boosting production at its owned and partnered manufacturing facilities.
The...
FDA recently completed an inspection of Emergent BioSolutions, a proposed manufacturing facility for Johnson & Johnson’s COVID-19 vaccine.
The agency’s assessments reviewed the...
A JAMA Network Open study found that COVID-19 treatments hydroxychloroquine and lopinavir-ritonavir failed to show any significant benefit in hospitalized patients.
The study analyzed metrics such...
New COVID-19 drug therapies along with better clinical management of patients with SARS-CoV-2 infection may have contributed to reductions in in-hospital COVID-19 mortality rates, according to a recent...
FDA and the CDC recently lifted the pause of the Johnson & Johnson COVID-19 vaccine in the US following a thorough safety review, including two meetings of the CDC’s Advisory Committee of...
Johnson & Johnson recently announced that the rollout of its COVID-19 vaccine will resume in Europe.
The European Medicines Agency’s (EMA’s) Pharmacovigilance Risk Assessment Committee...
FDA recently revoked the emergency use authorization that allowed for Eli Lilly & Company’s monoclonal COVID-19 antibody, bamlanivimab, to be used for coronavirus treatment in adults and...
FDA recently issued guidance on remote interactive evaluations of drug facilities where COVID-19 drugs are manufactured, processed, packaged, and held during the pandemic.
As part of the...
Eli Lilly and Company recently requested that FDA revoke the emergency use authorization for its COVID-19 antibody treatment.
The FDA’s authorization has allowed providers to use 700 milligrams...
Gilead recently announced that it has stopped the Phase 3 clinical trial studying remdesivir in high-risk, non-hospitalized COVID-19 patients.
The company stated that it no longer believes...
Roche recently confirmed positive results from the Phase 3 trial assessing its COVID-19 antibody cocktail, which aims to reduce coronavirus infection among household contacts of individuals infected...
The CDC and FDA are reviewing data involving six reported cases of a severe and rare kind of blood clot in individuals who received the Johnson & Johnson (Janssen) COVID-19 vaccine.
This comes...
The New England Journal of Medicine (NEJM) recently released antibody persistence data six months following the second dose of Moderna’s COVID-19 vaccine, mRNA-1273.
As detected by three...
Many European countries, including Germany, France, Italy, and Spain recently suspended the use of AstraZeneca’s COVID-19 vaccine after experts found dangerous blood clots in some vaccine...
The Biden Administration recently appointed Johnson & Johnson to lead COVID-19 vaccine production at a Baltimore manufacturing plant that contaminated 15 million doses of the pharmaceutical...
FDA recently announced two revisions regarding the number of doses per vial available for Moderna’s COVID-19 vaccine, mRNA-1273.
The agency’s first revision clarifies the number of doses...
NIH recently announced that it has started a Phase 1 clinical trial of Moderna’s variant-specific COVID-19 vaccine candidate, mRNA-1273.351.
Researchers will evaluate the safety and...
